CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Recorded on May 28, 2026

Tara Gregory, MD

President

Colorado Blood Cancer Institute

Denver, CO

Jay Spiegel, MD

Assistant Professor

Division of Transplant and Cellular Therapy

University of Miami Sylvester Comprehensive Cancer Center

Miami, FL

In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma and myeloma. They provide a practical overview of CAR-T, including currently approved indications, importance of early referral, patient selection considerations, and strategies for engaging patients in treatment discussions. The conversation also covers key aspects of toxicity management and post-treatment monitoring, while addressing current limitations of CAR-T therapy and future directions that may further expand its role in patient care. Tune in today for this exciting episode!